$MU
Micron Technology Inc Stock $mu

$mu Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000072312517000166 Filed on December 20, 2017

Income Statement

Concept	2017 Q4	2016 Q4
Revenue	$6.803B	$3.970B
YoY Change	71.36%	18.51%
Cost Of Revenue	$3.056B	$2.959B
YoY Change	3.28%	18.31%
Gross Profit	$3.747B	$1.011B
YoY Change	270.62%	19.08%
Gross Profit Margin	55.08%	25.47%
Selling, General & Admin	$191.0M	$159.0M
YoY Change	20.13%	-11.17%
% of Gross Profit	5.1%	15.73%
Research & Development	$448.0M	$470.0M
YoY Change	-4.68%	11.64%
% of Gross Profit	11.96%	46.49%
Depreciation & Amortization	$1.090B	$744.0M
YoY Change	46.51%	5.38%
% of Gross Profit	29.09%	73.59%
Operating Expenses	$639.0M	$629.0M
YoY Change	1.59%	4.83%
Operating Profit	$3.097B	$359.0M
YoY Change	762.67%	54.74%
Interest Expense	$124.0M	$139.0M
YoY Change	-10.79%	44.79%
% of Operating Profit	4.0%	38.72%
Other Income/Expense, Net	-$204.0M	-$14.00M
YoY Change	1357.14%	250.0%
Pretax Income	$2.792B	$213.0M
YoY Change	1210.8%	48.95%
Income Tax	$114.0M	$31.00M
% Of Pretax Income	4.08%	14.55%
Net Earnings	$2.678B	$180.0M
YoY Change	1387.78%	-12.62%
Net Earnings / Revenue	39.36%	4.53%
Basic Earnings Per Share	$2.36	$0.17
Diluted Earnings Per Share	$2.19	$0.16
COMMON SHARES
Basic Shares Outstanding	1.134B shares	1.040B shares
Diluted Shares Outstanding	1.225B shares	1.091B shares

Balance Sheet

Concept	2017 Q4	2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.174B	$4.169B
YoY Change	48.09%	14.5%
Cash & Equivalents	$6.008B	$4.139B
Short-Term Investments	$166.0M	$30.00M
Other Short-Term Assets	$148.0M	$132.0M
YoY Change	12.12%	-37.44%
Inventory	$3.160B	$2.750B
Prepaid Expenses
Receivables	$3.603B	$2.162B
Other Receivables	$167.0M	$291.0M
Total Short-Term Assets	$13.36B	$9.504B
YoY Change	40.55%	11.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$20.72B	$15.32B
YoY Change	35.26%	38.53%
Goodwill	$1.228B
YoY Change
Intangibles	$368.0M	$445.0M
YoY Change	-17.3%	-16.98%
Long-Term Investments	$314.0M	$1.401B
YoY Change	-77.59%	3.7%
Other Assets	$469.0M	$411.0M
YoY Change	14.11%	-27.26%
Total Long-Term Assets	$23.83B	$18.33B
YoY Change	30.01%	15.46%
TOTAL ASSETS
Total Short-Term Assets	$13.36B	$9.504B
Total Long-Term Assets	$23.83B	$18.33B
Total Assets	$37.19B	$27.84B
YoY Change	33.61%	14.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.209B	$1.304B
YoY Change	-7.29%	28.6%
Accrued Expenses	$460.0M	$351.0M
YoY Change	31.05%	4.78%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.401B	$1.155B
YoY Change	21.3%	9.9%
Total Short-Term Liabilities	$5.583B	$5.546B
YoY Change	0.67%	37.79%
LONG-TERM LIABILITIES
Long-Term Debt	$7.662B	$8.521B
YoY Change	-10.08%	33.81%
Other Long-Term Liabilities	$553.0M	$601.0M
YoY Change	-7.99%	-16.53%
Total Long-Term Liabilities	$553.0M	$601.0M
YoY Change	-7.99%	-16.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.583B	$5.546B
Total Long-Term Liabilities	$553.0M	$601.0M
Total Liabilities	$13.78B	$14.64B
YoY Change	-5.86%	32.21%
SHAREHOLDERS EQUITY
Retained Earnings	$12.94B	$5.469B
YoY Change	136.57%	-5.51%
Common Stock	$9.564B	$7.887B
YoY Change	21.26%	3.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$22.53B	$12.32B
YoY Change
Total Liabilities & Shareholders Equity	$37.19B	$27.84B
YoY Change	33.61%	14.14%

Cashflow Statement

Concept	2017 Q4	2016 Q4
OPERATING ACTIVITIES
Net Income	$2.678B	$180.0M
YoY Change	1387.78%	-12.62%
Depreciation, Depletion And Amortization	$1.090B	$744.0M
YoY Change	46.51%	5.38%
Cash From Operating Activities	$3.636B	$1.138B
YoY Change	219.51%	1.61%
INVESTING ACTIVITIES
Capital Expenditures	$1.956B	$1.264B
YoY Change	54.75%	27.68%
Acquisitions
YoY Change
Other Investing Activities	-$69.00M	-$11.00M
YoY Change	527.27%	-106.96%
Cash From Investing Activities	-$1.434B	-$936.0M
YoY Change	53.21%	41.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	-$1.337B	$13.00M
YoY Change	-10384.62%	-90.37%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.282B	-$212.0M
YoY Change	504.72%	51.43%
NET CHANGE
Cash From Operating Activities	$3.636B	$1.138B
Cash From Investing Activities	-$1.434B	-$936.0M
Cash From Financing Activities	-$1.282B	-$212.0M
Net Change In Cash	$914.0M	-$52.00M
YoY Change	-1857.69%	-116.25%
FREE CASH FLOW
Cash From Operating Activities	$3.636B	$1.138B
Capital Expenditures	$1.956B	$1.264B
Free Cash Flow	$1.680B	-$126.0M
YoY Change	-1433.33%	-196.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q4	dei	Amendment Flag AmendmentFlag	false
CY2017Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--08-30
CY2017Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2017Q4	dei	Document Period End Date DocumentPeriodEndDate	2017-11-30
CY2017Q4	dei	Document Type DocumentType	10-Q
CY2017Q4	dei	Entity Central Index Key EntityCentralIndexKey	0000723125
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1156314972	shares
CY2017Q4	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q4	dei	Entity Registrant Name EntityRegistrantName	MICRON TECHNOLOGY INC
CY2016Q4	mu	Business Acquisition Pro Forma Net Income Loss Including Portion Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossIncludingPortionAttributabletoNoncontrollingInterest	190000000	USD
CY2016Q4	mu	Depreciationand Amortizationof Intangible Assets DepreciationandAmortizationofIntangibleAssets	771000000	USD
CY2017Q4	mu	Depreciationand Amortizationof Intangible Assets DepreciationandAmortizationofIntangibleAssets	1090000000	USD
CY2017Q3	mu	Equipment Purchase Payable Current EquipmentPurchasePayableCurrent	1018000000	USD
CY2017Q4	mu	Equipment Purchase Payable Current EquipmentPurchasePayableCurrent	1314000000	USD
CY2016Q4	mu	Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet	-2000000	USD
CY2016Q4	mu	Payments On Equipment Purchase Contracts PaymentsOnEquipmentPurchaseContracts	24000000	USD
CY2017Q4	mu	Payments On Equipment Purchase Contracts PaymentsOnEquipmentPurchaseContracts	133000000	USD
CY2016Q4	mu	Proceeds For Derivative And Hedge Investing Activities ProceedsForDerivativeAndHedgeInvestingActivities	7000000	USD
CY2017Q4	mu	Proceeds For Derivative And Hedge Investing Activities ProceedsForDerivativeAndHedgeInvestingActivities	28000000	USD
CY2017Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3664000000	USD
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3766000000	USD
CY2017Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	350000000	USD
CY2017Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	352000000	USD
CY2017Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1333000000	USD
CY2017Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1209000000	USD
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3490000000	USD
CY2016Q4	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	3965000000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5109000000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6008000000	USD
CY2016Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4263000000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4211000000	USD
CY2017Q4	mu	Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet	-195000000	USD
CY2016Q4	mu	Payments For Derivative And Hedge Investing Activities PaymentsForDerivativeAndHedgeInvestingActivities	173000000	USD
CY2017Q4	mu	Payments For Derivative And Hedge Investing Activities PaymentsForDerivativeAndHedgeInvestingActivities	17000000	USD
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5216000000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3603000000	USD
CY2017Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22102000000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22875000000	USD
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	29000000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	24000000	USD
CY2017Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8287000000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	9448000000	USD
CY2016Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	32000000	USD
CY2017Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	29000000	USD
CY2016Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	64000000	shares
CY2017Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2000000	shares
CY2017Q3	us-gaap	Assets Assets	35336000000	USD
CY2017Q4	us-gaap	Assets Assets	37191000000	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	12457000000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	13358000000	USD
CY2017Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	6045000000	USD
CY2017Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	6488000000	USD
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2017Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	319000000	USD
CY2017Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	166000000	USD
CY2017Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	617000000	USD
CY2017Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	314000000	USD
CY2016Q4	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	0.17
CY2016Q4	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	0.17
CY2016Q4	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	190000000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6130000000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-52000000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	914000000	USD
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1116000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1158000000	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1112000000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1158000000	shares
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	112000000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	116000000	USD
CY2016Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	208000000	USD
CY2017Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2673000000	USD
CY2016Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2017Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2016Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	208000000	USD
CY2017Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2673000000	USD
CY2016Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2959000000	USD
CY2017Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3056000000	USD
CY2017Q3	us-gaap	Customer Advances Current CustomerAdvancesCurrent	197000000	USD
CY2017Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	198000000	USD
CY2017Q3	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	11134000000	USD
CY2017Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	9045000000	USD
CY2017Q3	us-gaap	Debt Current DebtCurrent	1262000000	USD
CY2017Q4	us-gaap	Debt Current DebtCurrent	1401000000	USD
CY2016Q4	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	13000000	USD
CY2017Q4	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	26000000	USD
CY2017Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	766000000	USD
CY2017Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	731000000	USD
CY2017Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	408000000	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	416000000	USD
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.36
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.19
CY2016Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-42000000	USD
CY2017Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-6000000	USD
CY2017Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	603000000	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	460000000	USD
CY2017Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	348000000	USD
CY2017Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y2M
CY2017Q4	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	2360000000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	477000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	493000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	73000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	19000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	28000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	33000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	50000000	USD
CY2016Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-12000000	USD
CY2017Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-9000000	USD
CY2016Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1000000	USD
CY2017Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-195000000	USD
CY2017Q3	us-gaap	Goodwill Goodwill	1228000000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	1228000000	USD
CY2016Q4	us-gaap	Gross Profit GrossProfit	1011000000	USD
CY2017Q4	us-gaap	Gross Profit GrossProfit	3747000000	USD
CY2016Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	213000000	USD
CY2017Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2792000000	USD
CY2016Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2000000	USD
CY2017Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2016Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31000000	USD
CY2017Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	114000000	USD
CY2016Q4	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	40000000	USD
CY2017Q4	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	391000000	USD
CY2016Q4	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.04
CY2017Q4	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.32
CY2017Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	100000000	USD
CY2017Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	106000000	USD
CY2016Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	299000000	USD
CY2017Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-261000000	USD
CY2016Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-139000000	USD
CY2017Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	37000000	USD
CY2016Q4	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	401000000	USD
CY2017Q4	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	121000000	USD
CY2017Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	864000000	USD
CY2017Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	861000000	USD
CY2017Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	387000000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	368000000	USD
CY2016Q4	us-gaap	Interest Expense InterestExpense	139000000	USD
CY2017Q4	us-gaap	Interest Expense InterestExpense	124000000	USD
CY2017Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	856000000	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	874000000	USD
CY2017Q3	us-gaap	Inventory Net InventoryNet	3123000000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	3160000000	USD
CY2017Q3	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	299000000	USD
CY2017Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	329000000	USD
CY2017Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1968000000	USD
CY2017Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1957000000	USD
CY2016Q4	us-gaap	Investment Income Net InvestmentIncomeNet	7000000	USD
CY2017Q4	us-gaap	Investment Income Net InvestmentIncomeNet	23000000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	15845000000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	13780000000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35336000000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37191000000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5334000000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5583000000	USD
CY2017Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	9872000000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	7644000000	USD
CY2017Q3	us-gaap	Minority Interest MinorityInterest	849000000	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	867000000	USD
CY2016Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-212000000	USD
CY2017Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1282000000	USD
CY2016Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-936000000	USD
CY2017Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1434000000	USD
CY2016Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1138000000	USD
CY2017Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3636000000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	180000000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	2678000000	USD
CY2016Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2017Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2016Q4	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	180000000	USD
CY2017Q4	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	2678000000	USD
CY2017Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	359000000	USD
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	3097000000	USD
CY2017Q3	us-gaap	Other Assets Current OtherAssetsCurrent	147000000	USD
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	148000000	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	450000000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	469000000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1000000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1000000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-7000000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-3000000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	37000000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	28000000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-5000000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	1000000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	1000000	USD
CY2017Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	639000000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	553000000	USD
CY2016Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-14000000	USD
CY2017Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-204000000	USD
CY2016Q4	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	71000000	USD
CY2017Q4	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	12000000	USD
CY2016Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-23000000	USD
CY2017Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-11000000	USD
CY2017Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	169000000	USD
CY2017Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	167000000	USD
CY2016Q4	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	18000000	USD
CY2017Q4	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	88000000	USD
CY2016Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-11000000	USD
CY2017Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-58000000	USD
CY2016Q4	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	84000000	USD
CY2017Q4	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	186000000	USD
CY2016Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1264000000	USD
CY2017Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1956000000	USD
CY2017Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1360000000	USD
CY2016Q4	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	16000000	USD
CY2017Q4	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	150000000	USD
CY2016Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	29000000	USD
CY2017Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1472000000	USD
CY2016Q4	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	55000000	USD
CY2017Q4	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	85000000	USD
CY2016Q4	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-45000000	USD
CY2017Q4	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-27000000	USD
CY2016Q4	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	512000000	USD
CY2017Q4	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	554000000	USD
CY2016Q4	us-gaap	Profit Loss ProfitLoss	180000000	USD
CY2017Q4	us-gaap	Profit Loss ProfitLoss	2678000000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	41533000000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	43598000000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19431000000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20723000000	USD
CY2017Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	3759000000	USD
CY2017Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	3876000000	USD
CY2016Q4	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	188000000	USD
CY2017Q4	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	2744000000	USD
CY2016Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	470000000	USD
CY2017Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	448000000	USD
CY2017Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	107000000	USD
CY2017Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	122000000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	10260000000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12938000000	USD
CY2016Q4	us-gaap	Sales Revenue Net SalesRevenueNet	3970000000	USD
CY2017Q4	us-gaap	Sales Revenue Net SalesRevenueNet	6803000000	USD
CY2016Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	159000000	USD
CY2017Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	191000000	USD
CY2016Q4	us-gaap	Share Based Compensation ShareBasedCompensation	46000000	USD
CY2017Q4	us-gaap	Share Based Compensation ShareBasedCompensation	51000000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	99000000	shares
CY2017Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	41.00
CY2017Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	34000000	shares
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	18621000000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	22526000000	USD
CY2017Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	19470000000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23393000000	USD
CY2017Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	163000000	USD
CY2017Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	233000000	USD
CY2017Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	21000000	USD
CY2017Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	18000000	USD
CY2017Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	4000000	shares
CY2017Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0	shares
CY2017Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	67000000	USD
CY2017Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	0	USD
CY2016Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	51000000	shares
CY2017Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	91000000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1091000000	shares
CY2017Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1225000000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1040000000	shares
CY2017Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1134000000	shares
CY2017Q4	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Recently Issued Accounting Standards</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-16 – </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intra-Entity Transfers Other Than Inventory</font><font style="font-family:inherit;font-size:10pt;">, which requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. This ASU will be effective for us in the first quarter of 2019 and requires modified retrospective adoption. We are evaluating the effects of our adoption of this ASU on our financial statements.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU 2016-13 – </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Measurement of Credit Losses on Financial Instruments</font><font style="font-family:inherit;font-size:10pt;">, which requires a financial asset (or a group of financial assets) measured on the basis of amortized cost to be presented at the net amount expected to be collected. This ASU requires that the income statement reflect the measurement of credit losses for newly recognized financial assets as well as the expected increases or decreases of expected credit losses that have taken place during the period. This ASU requires that credit losses of debt securities designated as available-for-sale be recorded through an allowance for credit losses and limits the credit loss to the amount by which fair value is below amortized cost. This ASU will be effective for us in the first quarter of 2021 with adoption permitted as early as the first quarter of 2020. This ASU requires modified retrospective adoption, with prospective adoption for debt securities for which an other-than-temporary impairment had been recognized before the effective date. We are evaluating the timing and effects of our adoption of this ASU on our financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02 – </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;">, which amends a number of aspects of lease accounting, including requiring lessees to recognize operating leases with a term greater than one year on their balance sheet as a right-of- use asset and corresponding liability, measured at the present value of the lease payments. This ASU will be effective for us in the first quarter of 2020 with early adoption permitted and requires modified retrospective adoption. The adoption of this ASU will result in an increase in right-of-use assets and corresponding liabilities. We are evaluating the timing and other effects of our adoption of this ASU on our financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the FASB issued ASU 2016-01 – </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recognition and Measurement of Financial Assets and Financial Liabilities</font><font style="font-family:inherit;font-size:10pt;">, which provides guidance for the recognition, measurement, presentation, and disclosure of financial assets and liabilities. This ASU will be effective for us in the first quarter of 2019 and requires modified retrospective adoption. We are evaluating the effects of our adoption of this ASU on our financial statements.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU 2014-09 – </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">, which supersedes nearly all existing revenue recognition guidance under generally accepted accounting principles in the United States. The core principal of this ASU, as amended, is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments, and assets recognized from costs incurred to obtain or fulfill a contract. This ASU will be effective for us in the first quarter of 2019 and allows for either full retrospective or modified retrospective adoption. We expect that, as a result of the adoption of this ASU, the timing of recognizing revenue from sales of products to our distributors under agreements allowing rights of return or price protection will be generally earlier than under the existing revenue recognition guidance. Revenue recognized upon resale by our customers under these arrangements was </font><font style="font-family:inherit;font-size:10pt;">22%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">23%</font><font style="font-family:inherit;font-size:10pt;"> of our consolidated revenue for the first quarters of </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, respectively. After adoption, the impact of this change in any reporting period would be the net effect of changes to revenue recognized as of the beginning and end of each period. We are evaluating the method and other effects of our adoption of this ASU on our financial statements.</font></div></div>
CY2017Q4	us-gaap	Fiscal Period FiscalPeriod	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2018 and 2017 each contain 52 weeks. All period references are to our fiscal periods unless otherwise indicated.</font></div></div>
CY2017Q4	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date, including those described below. We are currently a party to other legal actions arising from the normal course of business, none of which are expected to have a material adverse effect on our business, results of operations, or financial condition.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Patent Matters</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As is typical in the semiconductor and other high-tech industries, from time to time, others have asserted, and may in the future assert, that our products or manufacturing processes infringe upon their intellectual property rights.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 21, 2014, Elm 3DS Innovations, LLC ("Elm") filed a patent infringement action against Micron, MSP, and Micron Consumer Products Group, Inc. in the U.S. District Court for the District of Delaware. On March 27, 2015, Elm filed an amended complaint against the same entities. The amended complaint alleges that unspecified semiconductor products of ours that incorporate multiple stacked die infringe </font><font style="font-family:inherit;font-size:10pt;">13</font><font style="font-family:inherit;font-size:10pt;"> U.S. patents and seeks damages, attorneys' fees, and costs.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 15, 2014, Innovative Memory Solutions, Inc. filed a patent infringement action against Micron in the U.S. District Court for the District of Delaware. The complaint alleges that a variety of our NAND products infringe </font><font style="font-family:inherit;font-size:10pt;">eight</font><font style="font-family:inherit;font-size:10pt;"> U.S. patents and seeks damages, attorneys' fees, and costs.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 24, 2016, the President and Fellows of Harvard University filed a patent infringement action against Micron in the U.S. District Court for the District of Massachusetts. The complaint alleges that a variety of our DRAM products infringe </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> U.S. patents and seeks damages, injunctive relief, and other unspecified relief.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Among other things, the above lawsuits pertain to certain of our DDR DRAM, DDR2 DRAM, DDR3 DRAM, DDR4 DRAM, SDR SDRAM, PSRAM, RLDRAM, LPDRAM, NAND, and certain other memory products we manufacture, which account for a significant portion of our net sales.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of assertions of infringement made against us and therefore cannot estimate the range of possible loss. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing could have a material adverse effect on our business, results of operations, or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Qimonda</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda's insolvency proceedings, filed suit against Micron and Micron Semiconductor B.V., our Netherlands subsidiary ("Micron B.V."), in the District Court of Munich, Civil Chamber. The complaint seeks to void, under Section 133 of the German Insolvency Act, a share purchase agreement between Micron B.V. and Qimonda signed in fall 2008, pursuant to which Micron B.V. purchased substantially all of Qimonda's shares of Inotera (the "Inotera Shares"), representing approximately </font><font style="font-family:inherit;font-size:10pt;">18%</font><font style="font-family:inherit;font-size:10pt;"> of Inotera's outstanding shares as of </font><font style="font-family:inherit;font-size:10pt;">November 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, and seeks an order requiring us to re-transfer those shares to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate, under Sections 103 or 133 of the German Insolvency Code, a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Following a series of hearings with pleadings, arguments, and witnesses on behalf of the Qimonda estate, on March 13, 2014, the court issued judgments: (1) ordering Micron B.V. to pay approximately </font><font style="font-family:inherit;font-size:10pt;">$1 million</font><font style="font-family:inherit;font-size:10pt;"> in respect of certain Inotera Shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on the Inotera Shares and all other benefits; (4) denying Qimonda's claims against Micron for any damages relating to the joint venture relationship with Inotera; and (5) determining that Qimonda's obligations under the patent cross-license agreement are canceled. In addition, the court issued interlocutory judgments ordering, among other things: (1) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by Micron B.V. and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by Micron B.V. from ownership of the Inotera Shares. The interlocutory judgments have no immediate, enforceable effect on us, and, accordingly, we expect to be able to continue to operate with full control of the Inotera Shares subject to further developments in the case. We have filed a notice of appeal, and the parties have submitted briefs to the appeals court.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of the matter and therefore cannot estimate the range of possible loss. The final resolution of this lawsuit could result in the loss of the Inotera Shares or monetary damages, unspecified damages based on the benefits derived by Micron B.V. from the ownership of the Inotera Shares, and/or the termination of the patent cross-license, which could have a material adverse effect on our business, results of operation, or financial condition.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Other</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations, or financial condition.</font></div></div>
CY2017Q4	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior period amounts to conform to current period presentation.</font></div></div>

Files In Submission

Name	View Source	Status
0000723125-17-000166-index-headers.html	Edgar Link	pending
0000723125-17-000166-index.html	Edgar Link	pending
0000723125-17-000166.txt	Edgar Link	pending
0000723125-17-000166-xbrl.zip	Edgar Link	pending
a2018q1.htm	Edgar Link	pending
a2018q1ex10-70xssseverance.htm	Edgar Link	pending
a2018q1ex10-73creditagree.htm	Edgar Link	pending
a2018q1ex10-74xmbseverance.htm	Edgar Link	pending
a2018q1ex31-1xceocert.htm	Edgar Link	pending
a2018q1ex31-2xcfocert.htm	Edgar Link	pending
a2018q1ex32-1x906ceocert.htm	Edgar Link	pending
a2018q1ex32-2x906cfocert.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mu-20171130.xml	Edgar Link	completed
mu-20171130.xsd	Edgar Link	pending
mu-20171130_cal.xml	Edgar Link	unprocessable
mu-20171130_def.xml	Edgar Link	unprocessable
mu-20171130_lab.xml	Edgar Link	unprocessable
mu-20171130_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MU
Micron Technology Inc Stock $mu

2017 Q4 Form 10-Q Financial Statement

#000072312517000166 Filed on December 20, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MU Micron Technology Inc Stock $mu

2017 Q4 Form 10-Q Financial Statement

#000072312517000166 Filed on December 20, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MU
Micron Technology Inc Stock $mu